Cost effectiveness of budesonide/formoterol in a single inhaler for COPD compared with each monocomponent used alone
Objective: To compare the healthcare costs and effects of budesonide/formoterol in,a single inhaler with those of budesonide and formoterol monotherapies, and placebo, in a multinational study in patients with chronic obstructive pulmonary disease (COPD), National Heart, Lung and Blood Institute (NHLBI)/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) stages III or IV. Previous an
